These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30315646)

  • 21. Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis.
    McClung MR; Boonen S; Törring O; Roux C; Rizzoli R; Bone HG; Benhamou CL; Lems WF; Minisola S; Halse J; Hoeck HC; Eastell R; Wang A; Siddhanti S; Cummings SR
    J Bone Miner Res; 2012 Jan; 27(1):211-8. PubMed ID: 21976367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of endogenous estradiol protect bone mineral density in young postmenopausal women.
    Bagur A; Oliveri B; Mautalen C; Belotti M; Mastaglia S; Yankelevich D; Sayegh F; Royer M
    Climacteric; 2004 Jun; 7(2):181-8. PubMed ID: 15497907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    Yonsei Med J; 2004 Aug; 45(4):676-82. PubMed ID: 15344210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors.
    Cosman F; Hattersley G; Hu MY; Williams GC; Fitzpatrick LA; Black DM
    J Bone Miner Res; 2017 Jan; 32(1):17-23. PubMed ID: 27612281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on Risk Factors of Primary Non-traumatic OVCF in Chinese Elderly and a Novel Prediction Model.
    Wen Z; Mo X; Zhao S; Qi Z; Fu D; Wen S; Cheung WH; Chen B
    Orthop Surg; 2022 Nov; 14(11):2925-2938. PubMed ID: 36168985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
    Gallagher JC; Goldgar D
    Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin and bone status in men: analysis of the MINOS cohort.
    Breuil V; Fontas E; Chapurlat R; Panaia-Ferrari P; Yahia HB; Faure S; Euller-Ziegler L; Amri EZ; Szulc P
    Osteoporos Int; 2015 Dec; 26(12):2877-82. PubMed ID: 26109496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women.
    Kuchuk NO; van Schoor NM; Pluijm SM; Smit JH; de Ronde W; Lips P
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):295-303. PubMed ID: 17555504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
    Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis?
    Sahin G; Guler H; Incel N; Sezgin M; As I
    Int J Fertil Womens Med; 2006; 51(2):70-4. PubMed ID: 16881382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [COMPARISON OF EFFECTIVENESS BETWEEN PERCUTANEOUS VERTEBROPLASTY AND PERCUTANEOUS KYPHOPLASTY FOR TREATMENT OF OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURE WITH INTRAVERTEBRAL VACUUM CLEFT].
    Yu W; Liang D; Jiang X; Ye L; Yao Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Sep; 30(9):1104-1110. PubMed ID: 29786364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
    Sahota O; Fowler I; Blackwell PJ; Lawson N; Cawte SA; San P; Masud T; Hosking DJ
    Osteoporos Int; 2000; 11(11):959-66. PubMed ID: 11193249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.